ChromaDex Corporation
US ˙ NasdaqCM ˙ US1710774076
QUESTO SIMBOLO NON E' PIU' ATTIVO

SecurityCDXC / ChromaDex Corporation
InstitutionUBS Group AG
Latest Disclosed Ownership1,405,531 shares
Latest Disclosed Value $ 6,198,392
UBS Group AG reports 0.44% decrease in ownership of CDXC / ChromaDex Corporation

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 1,405,531 shares of ChromaDex Corporation (US:CDXC) valued at $6,198,392 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 1,411,742 shares of ChromaDex Corporation. This represents a change in shares of -0.44% during the quarter. The current value of the position is $11,061,529 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 1,405,531 -6,211 -0.44 6,198 -30.96 0.0002
2026-01-29 2025-12-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 1,411,742 215,645 18.03 8,979 -19.54 0.0015
2025-11-13 2025-09-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 1,196,097 1,110,441 1,296.40 11,160 804.29 0.0017
2025-08-14 2025-06-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 85,656 30,520 55.35 1,234 224.74 0.0002
2025-05-13 2025-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 55,136 10,663 23.98 380 61.70 0.0001
2025-02-14 2024-12-31 13F CHROMADEX COM NEW 171077407 44,473 -14,416 -24.48 236 9.81 0.0000
2024-11-14 2024-09-30 13F CHROMADEX COM NEW 171077407 58,889 -80,857 -57.86 215 -43.83 0.0000
2024-08-14 2024-06-30 13F CHROMADEX COM NEW 171077407 139,746 119,723 597.93 382 452.17 0.0001
2024-05-13 2024-03-31 13F CHROMADEX COM NEW 171077407 20,023 18,570 1,278.05 70 3,350.00 0.0000
2024-02-09 2023-12-31 13F CHROMADEX COM NEW 171077407 1,453 394 37.20 2 100.00 0.0000
2023-11-09 2023-09-30 13F CHROMADEX COM NEW 171077407 1,059 -5,467 -83.77 2 -90.00 0.0000
2023-08-11 2023-06-30 13F CHROMADEX COM NEW 171077407 6,526 -11,089 -62.95 10 -61.54 0.0000
2023-05-12 2023-03-31 13F CHROMADEX COM NEW 171077407 17,615 206 1.18 27 -10.34 0.0000
2023-02-08 2022-12-31 13F CHROMADEX COM NEW 171077407 17,409 -6,500 -27.19 29 0.00 0.0000
2022-11-10 2022-09-30 13F CHROMADEX COM NEW 171077407 23,909 -516 -2.11 29 -29.27 0.0000
2022-08-10 2022-06-30 13F CHROMADEX COM NEW 171077407 24,425 2,750 12.69 41 -22.64 0.0000
2022-05-16 2022-03-31 13F CHROMADEX COM NEW 171077407 21,675 -33,334 -60.60 53 -74.27 0.0000
2022-02-14 2021-12-31 13F CHROMADEX COM NEW 171077407 55,009 2,389 4.54 206 -37.58 0.0001
2021-11-15 2021-09-30 13F CHROMADEX COM NEW 171077407 52,620 -46,801 -47.07 330 -66.33 0.0001
2021-08-13 2021-06-30 13F CHROMADEX COM NEW 171077407 99,421 48,617 95.70 980 106.75 0.0003
2021-05-12 2021-03-31 13F CHROMADEX COM NEW 171077407 50,804 -101,490 -66.64 474 -35.16 0.0002
2021-02-11 2020-12-31 13F CHROMADEX COM NEW 171077407 152,294 1,694 1.12 731 21.03 0.0002
2020-11-12 2020-09-30 13F CHROMADEX COM NEW 171077407 150,600 -51,281 -25.40 604 -34.77 0.0002
2020-07-31 2020-06-30 13F CHROMADEX COM NEW 171077407 201,881 -18,538 -8.41 926 28.79 0.0004
2020-05-01 2020-03-31 13F CHROMADEX COM NEW 171077407 220,419 -17,505 -7.36 719 -29.85 0.0003
2020-02-14 2019-12-31 13F CHROMADEX COM NEW 171077407 237,924 27,971 13.32 1,025 24.09 0.0004
2019-11-14 2019-09-30 13F CHROMADEX COM NEW 171077407 209,953 16,264 8.40 826 -8.22 0.0003
2019-08-14 2019-06-30 13F CHROMADEX COM NEW 171077407 193,689 -1,261 -0.65 900 10.16 0.0003
2019-05-14 2019-03-31 13F CHROMADEX COM NEW 171077407 194,950 42,607 27.97 817 56.21 0.0003
2019-02-14 2018-12-31 13F CHROMADEX COM NEW 171077407 152,343 7,281 5.02 523 -16.05 0.0002
2018-11-14 2018-09-30 13F CHROMADEX COM NEW 171077407 145,062 -642 -0.44 623 15.16 0.0002
2018-08-14 2018-06-30 13F CHROMADEX COM NEW 171077407 145,704 24,292 20.01 541 6.08 0.0002
2018-05-15 2018-03-31 13F CHROMADEX COM NEW 171077407 121,412 58,848 94.06 510 38.59 0.0002
2018-02-14 2017-12-31 13F CHROMADEX COM NEW 171077407 62,564 27,564 78.75 368 143.71 0.0002
2017-11-14 2017-09-30 13F CHROMADEX COM NEW 171077407 35,000 21,691 162.98 151 196.08 0.0001
2017-11-14 2017-06-30 13F/A-1 CHROMADEX COM NEW 171077407 13,309 -6,174 -31.69 51 -1.92 0.0000
2017-08-14 2017-06-30 13F CHROMADEX COM NEW 171077407 13,309 -6,174 51
2017-11-14 2017-03-31 13F/A-1 CHROMADEX COM NEW 171077407 19,483 182 0.94 52 -18.75 0.0000
2017-05-12 2017-03-31 13F CHROMADEX COM NEW 171077407 19,483 182 52
2017-02-14 2016-12-31 13F CHROMADEX COM NEW 171077407 19,301 6,301 48.47 64 64.10 0.0000
2016-11-14 2016-09-30 13F CHROMADEX COM NEW 171077407 13,000 -2,932 -18.40 39 -40.91 0.0000
2016-08-12 2016-06-30 13F CHROMADEX COM NEW 171077407 15,932 15,932 66 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.